CYP cynata therapeutics limited

Ann: Quarterly Activity Report & Appendix 4C, page-2

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Again most of the $$$ going straight into product R&D.

    $2.875m vs $485k G&A for a whole quarter.
    A great ratio again compared to most Biotech robbers

    Q NET $1.66m burnt.

    CASH: $16.4m (End DEC) Plus circa $2.9m cell manufacturing credit with FujiFilm for trials. paid last Q.

    Total $19.3m
    Minus say 800k for Jan.
    current $18.5m to work with rest 2023.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.015(9.68%)
Mkt cap ! $38.41M
Open High Low Value Volume
15.5¢ 17.0¢ 15.5¢ $47.10K 289.1K

Buyers (Bids)

No. Vol. Price($)
1 50000 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 23813 3
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.